Health TrialsbyHealthPanel

Effect of Panax Ginseng C.A. Mey Extract on Liver Function in Adults

ConditionLiver Diseases
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19-75
SponsorPusan National University Yangsan Hospital

About this trial

The investigators conduct a randomized, double-blind, placebo-controlled study to investigate the effects of Panax Ginseng C.A. Mey Extract on liver function in adults for 8 weeks.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

ALT ranging from upper limit of reference to three times of upper limit

Disqualifiers

Abnormal liver or renal function (i.e., serum aminotransferase activity > 3 times of upper limit of reference range and serum creatinine concentrations > 1.2 mg/dL)

Diabetes (diagnosed clinically or fasting glucose level > 126 mg/dL)

History of viral hepatitis or cancer

Uncontrolled hypertension

Trial design

Design model

Parallel

Treatments tested in this trial

  • Panax Ginseng C.A. Mey Extract group

    Dietary supplement

    This group takes Panax Ginseng C.A. Mey Extract for 8 weeks

  • Placebo group

    Dietary supplement

    This group takes placebo for 8 weeks

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Panax Ginseng C.A. Mey Extract groupExperimental treatment 1 intervention
Group B: Placebo groupPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Alanine aminotransferase

Alanine aminotransferase

Time frame
8 weeks

Secondary outcomes

1

Aspartate aminotransferase

Aspartate aminotransferase

Time frame
8 weeks
2

Gamma-glutamyl transferase

Gamma-glutamyl transferase

Time frame
8 weeks

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Pusan National University Yangsan Hospital

Lead sponsor

Source ClinicalTrials.gov
Apply now